[
  {
    "ts": "2025-11-21T00:20:15+00:00",
    "headline": "Evaluating Eli Lilly Shares After 30% Surge Driven by Obesity Drug Pipeline News",
    "summary": "Curious whether Eli Lilly’s stock is still a smart buy after its rapid rise? Let’s break down the numbers and see if the current price matches up with real value. Shares have vaulted higher lately, climbing 30.5% in just the last month and notching a stunning 40.2% gain over the past year. Investors are watching Eli Lilly closely after headline-making developments in its obesity and diabetes drug pipeline sent the stock to new highs. This reflects excitement over blockbuster potential and...",
    "url": "https://finance.yahoo.com/news/evaluating-eli-lilly-shares-30-002015560.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "1b85e004-fb57-39e6-ae95-5104ec899927",
      "content": {
        "id": "1b85e004-fb57-39e6-ae95-5104ec899927",
        "contentType": "STORY",
        "title": "Evaluating Eli Lilly Shares After 30% Surge Driven by Obesity Drug Pipeline News",
        "description": "",
        "summary": "Curious whether Eli Lilly’s stock is still a smart buy after its rapid rise? Let’s break down the numbers and see if the current price matches up with real value. Shares have vaulted higher lately, climbing 30.5% in just the last month and notching a stunning 40.2% gain over the past year. Investors are watching Eli Lilly closely after headline-making developments in its obesity and diabetes drug pipeline sent the stock to new highs. This reflects excitement over blockbuster potential and...",
        "pubDate": "2025-11-21T00:20:15Z",
        "displayTime": "2025-11-21T00:20:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uZWvuDuy6_Wr6cKvxAFZcw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g78F5NO5pySOmBHzFi6.eA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/evaluating-eli-lilly-shares-30-002015560.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/evaluating-eli-lilly-shares-30-002015560.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T00:01:48+00:00",
    "headline": "Analysts get more bullish on this non-tech stock",
    "summary": "The market has been swinging recently, with the S&P 500 index down 1.5% and the Nasdaq Composite down more than 2% over the past month. Investors are now questioning whether the tech momentum can continue. Some non-tech stocks have performed well, and Eli Lilly (LLY) is one of them. Eli ...",
    "url": "https://www.thestreet.com/investing/stocks/analysts-get-more-bullish-on-this-non-tech-stock",
    "source": "TheStreet",
    "provider": "yfinance",
    "raw": {
      "id": "4dee68ca-7a8f-3259-9326-a2642b37c982",
      "content": {
        "id": "4dee68ca-7a8f-3259-9326-a2642b37c982",
        "contentType": "STORY",
        "title": "Analysts get more bullish on this non-tech stock",
        "description": "",
        "summary": "The market has been swinging recently, with the S&P 500 index down 1.5% and the Nasdaq Composite down more than 2% over the past month. Investors are now questioning whether the tech momentum can continue. Some non-tech stocks have performed well, and Eli Lilly (LLY) is one of them. Eli ...",
        "pubDate": "2025-11-21T00:01:48Z",
        "displayTime": "2025-11-21T00:01:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/thestreet_881/736620a120e40adbbc536cd4720f4c7b",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/F_cqr7ObVav9uUsiftVcrg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/thestreet_881/736620a120e40adbbc536cd4720f4c7b.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vxESFjJPSwfyMp50xsym3Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/thestreet_881/736620a120e40adbbc536cd4720f4c7b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "TheStreet",
          "url": "https://www.thestreet.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thestreet.com/investing/stocks/analysts-get-more-bullish-on-this-non-tech-stock",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/analysts-more-bullish-non-tech-000148985.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T13:00:00+00:00",
    "headline": "9amHealth to Expand Access to Obesity Management Treatment through New Employer Health Benefits Offering",
    "summary": "9amHealth, a leader in virtual cardiometabolic care, today announced a new offering designed to make access to obesity management medications and care more sustainable for employers. The \"No-Barriers Bundle\" offers access to FDA-approved obesity medicines from Eli Lilly and Company (Lilly) and Novo Nordisk, along with 9amHealth's comprehensive cardiometabolic care program, creating a transparent, cost-efficient pathway for employers to support their teams' health.",
    "url": "https://finance.yahoo.com/news/9amhealth-expand-access-obesity-management-130000751.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "84991737-6937-3dd6-8a52-d51b4cf1ad8a",
      "content": {
        "id": "84991737-6937-3dd6-8a52-d51b4cf1ad8a",
        "contentType": "STORY",
        "title": "9amHealth to Expand Access to Obesity Management Treatment through New Employer Health Benefits Offering",
        "description": "",
        "summary": "9amHealth, a leader in virtual cardiometabolic care, today announced a new offering designed to make access to obesity management medications and care more sustainable for employers. The \"No-Barriers Bundle\" offers access to FDA-approved obesity medicines from Eli Lilly and Company (Lilly) and Novo Nordisk, along with 9amHealth's comprehensive cardiometabolic care program, creating a transparent, cost-efficient pathway for employers to support their teams' health.",
        "pubDate": "2025-11-21T13:00:00Z",
        "displayTime": "2025-11-21T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/0ff63062325cfc78d093cd96f33bfe41",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "(PRNewsfoto/9am.health Inc.)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/awWWj1Z4pRyVuwbWoyVm9g--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/0ff63062325cfc78d093cd96f33bfe41.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MgpCPssgeKAWHmaVPDccng--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/0ff63062325cfc78d093cd96f33bfe41.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/9amhealth-expand-access-obesity-management-130000751.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/9amhealth-expand-access-obesity-management-130000751.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T13:53:50+00:00",
    "headline": "Update: Market Chatter: Eli Lilly, Novo Nordisk to Offer GLP-1 Drugs Direct to Employers",
    "summary": "(Updates to add Waltz Health's comment in the seventh and eighth paragraphs.) Eli Lilly (LLY) and",
    "url": "https://finance.yahoo.com/news/market-chatter-eli-lilly-novo-135350521.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "937d7575-16e2-3305-8c53-1405928c8224",
      "content": {
        "id": "937d7575-16e2-3305-8c53-1405928c8224",
        "contentType": "STORY",
        "title": "Update: Market Chatter: Eli Lilly, Novo Nordisk to Offer GLP-1 Drugs Direct to Employers",
        "description": "",
        "summary": "(Updates to add Waltz Health's comment in the seventh and eighth paragraphs.) Eli Lilly (LLY) and",
        "pubDate": "2025-11-21T13:53:50Z",
        "displayTime": "2025-11-21T13:53:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/market-chatter-eli-lilly-novo-135350521.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/market-chatter-eli-lilly-novo-135350521.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T13:27:15+00:00",
    "headline": "Market Chatter: Eli Lilly, Novo Nordisk to Offer GLP-1 Drugs Direct to Employers",
    "summary": "Eli Lilly (LLY) and Novo Nordisk (NVO) are set to begin offering their popular GLP-1 medications to",
    "url": "https://finance.yahoo.com/news/market-chatter-eli-lilly-novo-132715677.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "3ae0f616-55e0-354d-8bec-fd8ef0abb207",
      "content": {
        "id": "3ae0f616-55e0-354d-8bec-fd8ef0abb207",
        "contentType": "STORY",
        "title": "Market Chatter: Eli Lilly, Novo Nordisk to Offer GLP-1 Drugs Direct to Employers",
        "description": "",
        "summary": "Eli Lilly (LLY) and Novo Nordisk (NVO) are set to begin offering their popular GLP-1 medications to",
        "pubDate": "2025-11-21T13:27:15Z",
        "displayTime": "2025-11-21T13:27:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/market-chatter-eli-lilly-novo-132715677.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/market-chatter-eli-lilly-novo-132715677.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T14:00:00+00:00",
    "headline": "Ilant Health Enhances Comprehensive Cardiometabolic Care with Direct Contracting for Obesity Management Medicine for Employers",
    "summary": "NEW YORK, November 21, 2025--Ilant Health announced that it will offer employers direct contracting and transparent pricing of Eli Lilly and Company (Lilly) obesity management medicines.",
    "url": "https://finance.yahoo.com/news/ilant-health-enhances-comprehensive-cardiometabolic-140000189.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "765c7b76-cca4-3af7-b887-fd0015aa0a81",
      "content": {
        "id": "765c7b76-cca4-3af7-b887-fd0015aa0a81",
        "contentType": "STORY",
        "title": "Ilant Health Enhances Comprehensive Cardiometabolic Care with Direct Contracting for Obesity Management Medicine for Employers",
        "description": "",
        "summary": "NEW YORK, November 21, 2025--Ilant Health announced that it will offer employers direct contracting and transparent pricing of Eli Lilly and Company (Lilly) obesity management medicines.",
        "pubDate": "2025-11-21T14:00:00Z",
        "displayTime": "2025-11-21T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ilant-health-enhances-comprehensive-cardiometabolic-140000189.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ilant-health-enhances-comprehensive-cardiometabolic-140000189.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T15:53:13+00:00",
    "headline": "BJ's beats on earnings, Ross lifts outlook, Eli Lilly hits $1T",
    "summary": "Market Catalysts host Julie Hyman tracks several of Friday's top trending stock tickers, including Eli Lilly (LLY), BJ's Wholesale Club (BJ), and Ross Stores (ROST). To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Catalysts.",
    "url": "https://finance.yahoo.com/video/bjs-beats-earnings-ross-lifts-155313821.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "1edf126f-f9f2-3d85-aea9-7de2c88e0dc1",
      "content": {
        "id": "1edf126f-f9f2-3d85-aea9-7de2c88e0dc1",
        "contentType": "VIDEO",
        "title": "BJ's beats on earnings, Ross lifts outlook, Eli Lilly hits $1T",
        "description": "<p>Market Catalysts host <a data-i13n=\"cpos:1;pos:1\" href=\"https://www.yahoo.com/author/julie-hyman/?.tsrc=fin-srch\">Julie Hyman</a> tracks several of Friday's top trending stock tickers, including Eli Lilly (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/LLY\">LLY</a>), BJ's Wholesale Club (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/BJ\">BJ</a>), and Ross Stores (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/ROST\">ROST</a>).</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-catalysts/\">Market Catalysts</a>.</p>",
        "summary": "Market Catalysts host Julie Hyman tracks several of Friday's top trending stock tickers, including Eli Lilly (LLY), BJ's Wholesale Club (BJ), and Ross Stores (ROST). To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Catalysts.",
        "pubDate": "2025-11-21T15:53:13Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/1c26a230-c6f0-11f0-8fdc-e1950bc712b7",
          "originalWidth": 4003,
          "originalHeight": 2255,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rrVM.xlD1851zSeL3CoNLg--~B/aD0yMjU1O3c9NDAwMzthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/1c26a230-c6f0-11f0-8fdc-e1950bc712b7.cf.webp",
              "width": 4003,
              "height": 2255,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2Y0qpukteQv05PIrQ7YOYw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/1c26a230-c6f0-11f0-8fdc-e1950bc712b7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/bjs-beats-earnings-ross-lifts-155313821.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/bjs-beats-earnings-ross-lifts-155313821.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ROST"
            },
            {
              "symbol": "BJ"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T15:30:15+00:00",
    "headline": "Eli Lilly joins $1 trillion club as weight-loss drugs fuel growth",
    "summary": "Investing.com -- Eli Lilly reached $1 trillion in market value on Friday, with shares briefly touching an all-time high of $1,060, and becoming the first pharmaceutical company to ever achieve this milestone.",
    "url": "https://finance.yahoo.com/news/eli-lilly-joins-1-trillion-153015732.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "f7826fba-c155-342e-9c9f-f994faaf00ae",
      "content": {
        "id": "f7826fba-c155-342e-9c9f-f994faaf00ae",
        "contentType": "STORY",
        "title": "Eli Lilly joins $1 trillion club as weight-loss drugs fuel growth",
        "description": "",
        "summary": "Investing.com -- Eli Lilly reached $1 trillion in market value on Friday, with shares briefly touching an all-time high of $1,060, and becoming the first pharmaceutical company to ever achieve this milestone.",
        "pubDate": "2025-11-21T15:30:15Z",
        "displayTime": "2025-11-21T15:30:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-joins-1-trillion-153015732.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-joins-1-trillion-153015732.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T15:29:00+00:00",
    "headline": "Eli Lilly Touches $1 Trillion Market Cap on Booming Weight-Loss Drugs",
    "summary": "Lilly becomes the first pharmaceutical company to hit that threshold, joining a select club of mostly tech companies.",
    "url": "https://www.wsj.com/health/pharma/eli-lilly-reaches-1-trillion-market-cap-on-booming-weight-loss-drugs-f4664fa9?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "d0f65e48-c128-3cfb-91a1-1bae2b07e613",
      "content": {
        "id": "d0f65e48-c128-3cfb-91a1-1bae2b07e613",
        "contentType": "STORY",
        "title": "Eli Lilly Touches $1 Trillion Market Cap on Booming Weight-Loss Drugs",
        "description": "",
        "summary": "Lilly becomes the first pharmaceutical company to hit that threshold, joining a select club of mostly tech companies.",
        "pubDate": "2025-11-21T15:29:00Z",
        "displayTime": "2025-11-21T15:29:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/d0f65e48-c128-3cfb-91a1-1bae2b07e613/eli-lilly-touches-1-trillion.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/f5c9d70a99f3ffa69ebadd5212a03fdf",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5S_vNkgaTAXYa.ludgCo8Q--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/f5c9d70a99f3ffa69ebadd5212a03fdf.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0GnFyWx.S.4TdR0JjC3pUQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/f5c9d70a99f3ffa69ebadd5212a03fdf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/eli-lilly-reaches-1-trillion-market-cap-on-booming-weight-loss-drugs-f4664fa9?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "META"
            },
            {
              "symbol": "TSLA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T15:15:58+00:00",
    "headline": "This Month's Stock Trend Hasn't Been AI. Here's What's Been Climbing Instead",
    "summary": "Healthcare stocks have outperformed the broader market by nearly 10 percentage points this month as AI bubble concerns have weighed on tech stocks.",
    "url": "https://www.investopedia.com/this-month-s-stock-trend-hasn-t-been-ai-here-s-what-s-been-climbing-instead-healthcare-lly-regn-11854186",
    "source": "Investopedia",
    "provider": "yfinance",
    "raw": {
      "id": "c9860c85-0570-3d47-be22-d9c04e8ab290",
      "content": {
        "id": "c9860c85-0570-3d47-be22-d9c04e8ab290",
        "contentType": "STORY",
        "title": "This Month's Stock Trend Hasn't Been AI. Here's What's Been Climbing Instead",
        "description": "",
        "summary": "Healthcare stocks have outperformed the broader market by nearly 10 percentage points this month as AI bubble concerns have weighed on tech stocks.",
        "pubDate": "2025-11-21T15:15:58Z",
        "displayTime": "2025-11-21T15:15:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/investopedia_245/76a655fe25431e9e3df0ae3d6841e6ce",
          "originalWidth": 8192,
          "originalHeight": 5464,
          "caption": "Spencer Platt / Getty Images Healthcare stocks have risen this month while tech stocks have weighed on the broader market.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jbTDi6lXNFav5kkBAmCb0w--~B/aD01NDY0O3c9ODE5MjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/investopedia_245/76a655fe25431e9e3df0ae3d6841e6ce.cf.webp",
              "width": 8192,
              "height": 5464,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1e1M5qEcHg4paeA.iITG2g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/investopedia_245/76a655fe25431e9e3df0ae3d6841e6ce.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investopedia",
          "url": "https://www.investopedia.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investopedia.com/this-month-s-stock-trend-hasn-t-been-ai-here-s-what-s-been-climbing-instead-healthcare-lly-regn-11854186",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T14:55:43+00:00",
    "headline": "Eli Lilly becomes first pharma group to join $1tn club",
    "summary": "Eli Lilly’s weight-loss drugs have made it the first pharma company to hit a $1tn market valuation, a sharp turnaround from this summer when...",
    "url": "https://finance.yahoo.com/news/eli-lilly-becomes-first-pharma-145543608.html",
    "source": "Financial Times",
    "provider": "yfinance",
    "raw": {
      "id": "def3b2e4-687d-38b1-ad3e-883e70506201",
      "content": {
        "id": "def3b2e4-687d-38b1-ad3e-883e70506201",
        "contentType": "STORY",
        "title": "Eli Lilly becomes first pharma group to join $1tn club",
        "description": "",
        "summary": "Eli Lilly’s weight-loss drugs have made it the first pharma company to hit a $1tn market valuation, a sharp turnaround from this summer when...",
        "pubDate": "2025-11-21T14:55:43Z",
        "displayTime": "2025-11-21T14:55:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Financial Times",
          "url": "https://www.ft.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-becomes-first-pharma-145543608.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "TSLA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T14:50:02+00:00",
    "headline": "Here's Why Eli Lilly (LLY) is a Strong Momentum Stock",
    "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
    "url": "https://finance.yahoo.com/news/heres-why-eli-lilly-lly-145002111.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "b6c0db57-1483-3d45-8925-9f9933f5302d",
      "content": {
        "id": "b6c0db57-1483-3d45-8925-9f9933f5302d",
        "contentType": "STORY",
        "title": "Here's Why Eli Lilly (LLY) is a Strong Momentum Stock",
        "description": "",
        "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
        "pubDate": "2025-11-21T14:50:02Z",
        "displayTime": "2025-11-21T14:50:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9",
          "originalWidth": 1000,
          "originalHeight": 754,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ySW4yppQRAB0XpI0aj_Aag--~B/aD03NTQ7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9.cf.webp",
              "width": 1000,
              "height": 754,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/y7O9v2FlH8hDflZpTNqGwg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-eli-lilly-lly-145002111.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T14:00:00+00:00",
    "headline": "Goodpath Expands Access to Obesity Management Care and Medications Through New Transparent Offering",
    "summary": "Goodpath, the virtual integrative care clinic for chronic conditions, today announced a new access pathway for obesity management care and medications, if clinically appropriate. The pathway is designed to make evidence-based weight management more financially sustainable for employers. Goodpath's solution simplifies access to FDA-approved medications for obesity care, including Eli Lilly and Company's obesity management medicine, and reduces cost barriers for employers and members at a time of",
    "url": "https://finance.yahoo.com/news/goodpath-expands-access-obesity-management-140000134.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "8379ca62-7674-3c3f-86e4-ba50c692eea9",
      "content": {
        "id": "8379ca62-7674-3c3f-86e4-ba50c692eea9",
        "contentType": "STORY",
        "title": "Goodpath Expands Access to Obesity Management Care and Medications Through New Transparent Offering",
        "description": "",
        "summary": "Goodpath, the virtual integrative care clinic for chronic conditions, today announced a new access pathway for obesity management care and medications, if clinically appropriate. The pathway is designed to make evidence-based weight management more financially sustainable for employers. Goodpath's solution simplifies access to FDA-approved medications for obesity care, including Eli Lilly and Company's obesity management medicine, and reduces cost barriers for employers and members at a time of",
        "pubDate": "2025-11-21T14:00:00Z",
        "displayTime": "2025-11-21T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/7308b39e863b8fb39723d330a3529d6b",
          "originalWidth": 400,
          "originalHeight": 96,
          "caption": "Goodpath (PRNewsfoto/Goodpath)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5BCvhxhko1nreXdfx.MXCQ--~B/aD05Njt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/7308b39e863b8fb39723d330a3529d6b.cf.webp",
              "width": 400,
              "height": 96,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TRFj5VLT1fpD5_pdf6txLQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7308b39e863b8fb39723d330a3529d6b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/goodpath-expands-access-obesity-management-140000134.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/goodpath-expands-access-obesity-management-140000134.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T17:16:39+00:00",
    "headline": "Eli Lilly Becomes First Pharma To Join $1 Trillion Club Alongside Nvidia, Apple, Others",
    "summary": "Eli Lilly on Friday became the first health care company to top $1 trillion in market capitalization, joining a club of mostly tech names.",
    "url": "https://www.investors.com/news/technology/eli-lilly-trillion-dollar-club-tech-companies/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "ac2680b5-9f45-36e3-acaf-975bd086b298",
      "content": {
        "id": "ac2680b5-9f45-36e3-acaf-975bd086b298",
        "contentType": "STORY",
        "title": "Eli Lilly Becomes First Pharma To Join $1 Trillion Club Alongside Nvidia, Apple, Others",
        "description": "",
        "summary": "Eli Lilly on Friday became the first health care company to top $1 trillion in market capitalization, joining a club of mostly tech names.",
        "pubDate": "2025-11-21T17:16:39Z",
        "displayTime": "2025-11-21T17:16:39Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/ac2680b5-9f45-36e3-acaf-975bd086b298/eli-lilly-becomes-first.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/67464aa2598bc109a3cce706482c0735",
          "originalWidth": 1012,
          "originalHeight": 572,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/45lZaPmm8vZHt8t16Pv3Sw--~B/aD01NzI7dz0xMDEyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/67464aa2598bc109a3cce706482c0735.cf.webp",
              "width": 1012,
              "height": 572,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zVkqSTYjINnOUb2UYhN_og--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/67464aa2598bc109a3cce706482c0735.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/eli-lilly-trillion-dollar-club-tech-companies/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "AMZN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T16:49:55+00:00",
    "headline": "Top Midday Stories: Lilly Becomes First Pharma Company to Hit $1 Trillion Market Cap; Enviri to Sell Clean Earth to Veolia for $3.04 Billion",
    "summary": "The major US stock indexes were up in late-morning trading Friday as investors remained concerned ov",
    "url": "https://finance.yahoo.com/news/top-midday-stories-lilly-becomes-164955916.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "e028b42b-8414-355f-a14f-fd305d2a3b2e",
      "content": {
        "id": "e028b42b-8414-355f-a14f-fd305d2a3b2e",
        "contentType": "STORY",
        "title": "Top Midday Stories: Lilly Becomes First Pharma Company to Hit $1 Trillion Market Cap; Enviri to Sell Clean Earth to Veolia for $3.04 Billion",
        "description": "",
        "summary": "The major US stock indexes were up in late-morning trading Friday as investors remained concerned ov",
        "pubDate": "2025-11-21T16:49:55Z",
        "displayTime": "2025-11-21T16:49:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-stories-lilly-becomes-164955916.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-stories-lilly-becomes-164955916.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVRI"
            },
            {
              "symbol": "INTU"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T16:32:46+00:00",
    "headline": "Eli Lilly reaches $1 trillion market value for first time",
    "summary": "Weight-loss and diabetes drugs drive historic milestone",
    "url": "https://finance.yahoo.com/news/eli-lilly-reaches-1-trillion-163246114.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "e629dcdc-2231-397e-9d42-9d36ab8dc131",
      "content": {
        "id": "e629dcdc-2231-397e-9d42-9d36ab8dc131",
        "contentType": "STORY",
        "title": "Eli Lilly reaches $1 trillion market value for first time",
        "description": "",
        "summary": "Weight-loss and diabetes drugs drive historic milestone",
        "pubDate": "2025-11-21T16:32:46Z",
        "displayTime": "2025-11-21T16:32:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c",
          "originalWidth": 500,
          "originalHeight": 500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8b14zxH4BANQFraIfqB7ug--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c.cf.webp",
              "width": 500,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j_oIKXponyFLhltsjvcwTQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-reaches-1-trillion-163246114.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-reaches-1-trillion-163246114.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T15:19:00+00:00",
    "headline": "Healthcare ETFs to Buy as Big Pharma Rapidly Integrates AI",
    "summary": "LLY's expanding AI alliances highlight how pharma-tech partnerships are transforming healthcare and lifting key sector ETFs like XLV.",
    "url": "https://finance.yahoo.com/news/healthcare-etfs-buy-big-pharma-151900701.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e7a80a4d-e66f-3837-b0cc-f5e2c1404054",
      "content": {
        "id": "e7a80a4d-e66f-3837-b0cc-f5e2c1404054",
        "contentType": "STORY",
        "title": "Healthcare ETFs to Buy as Big Pharma Rapidly Integrates AI",
        "description": "",
        "summary": "LLY's expanding AI alliances highlight how pharma-tech partnerships are transforming healthcare and lifting key sector ETFs like XLV.",
        "pubDate": "2025-11-21T15:19:00Z",
        "displayTime": "2025-11-21T15:19:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/57.Lfvcoa8N_9pHFAUTShA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/39hBnd4FwGlouiqapgQKxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/healthcare-etfs-buy-big-pharma-151900701.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/healthcare-etfs-buy-big-pharma-151900701.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "VHCIX"
            },
            {
              "symbol": "VHT"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]